The document discusses various liver diseases including Budd Chiari Syndrome, Post Necrotic Cirrhosis, and Cholangiocarcinoma. It provides details on the clinical features, pathogenesis, histopathological findings, grading systems, and case reports for each condition. The document serves as an overview on these liver diseases for medical practitioners.
cytochemical stains. CML versus Leukamoid. LAP score. NAP score. Hematology, Hematopathology. Lab technology. Pahology. Medical Laboratory. White cell stains
cytochemical stains. CML versus Leukamoid. LAP score. NAP score. Hematology, Hematopathology. Lab technology. Pahology. Medical Laboratory. White cell stains
Simple way to explain primary haemostatic anomalies
Easy to teach
Platelet function as well as disorders of granules and their release reaction. A reader will find a few better resources.
Outline is from introduction to explanation of every single anomaly. Happy reading
Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD);Flowcytometric...Dr Siddartha
Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD);Flowcytometric Evaluation
Basavatarakam Indo-American Cancer Hospital and Research Institute
Simple way to explain primary haemostatic anomalies
Easy to teach
Platelet function as well as disorders of granules and their release reaction. A reader will find a few better resources.
Outline is from introduction to explanation of every single anomaly. Happy reading
Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD);Flowcytometric...Dr Siddartha
Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD);Flowcytometric Evaluation
Basavatarakam Indo-American Cancer Hospital and Research Institute
Cirrhosis of liver is the end result of the hepatocellular injury
characterized by the presence of extensive fibrosis,
regenerative nodules and loss of liver architecture.
Urinary system – common pathological correlationKochi Chia
Presentation on common urinary system pathologies and radiological findings. Just a brief explanation. Further info can be obtained from www.radiopaedia.org and www.radiologyassistant.nl
Medical Surgical Nursing - I
UNIT: IV -Nursing Management of Patients With Disorder of Digestive System "Cirrhosis of liver"
the topic covers
- the stages, Pathophysiology and clinical manifestation of Cirrhosis of liver
- diagnostic evaluation and complication of Cirrhosis of liver
- medical, surgical and nursing management of patient with Cirrhosis of liver
Similar to LIVER HISTOPATHOLOGY (Budd chiari syndrome, Cirrohosis, Chlangiocarcinoma) (20)
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
1. Budd Chiari Syndrome,
Post Necrotic Cirrhosis,
Cholangiocarcinoma
Presented by: Dr. Shubhi Saxena
Moderator: Dr. M.L. Yadav
2. The Right Lobe The Left Lobe
VIII
V
IV
IV
III
II
VII
VI
• Each segment receives its own portal
pedicle (triad of portal vein, hepatic
artery, and bile duct).
Liver Segments
• composed of 4
lobes (left, right,
caudate, quadrate)
and divided into 8
segments
3.
4. HEPATOCYTES
• Hepatocytes are the large polyhedral cells with round nuclei with
peripherally dispersed chromatin and prominent nucleoli.
• The may be tetraploid or polyploid.
• Binucleate cells are also common in normal liver.
• The cytoplasm is strongly eosinophilic due to numerous
mitochondria with a fine basophilic granularity due to extensive free
ribosomes and rough endoplasmic reticulum.
• Fine brown granules of ‘wear and tear’ pigment lipofuscin are
present in variable amount.
• The sinusoids are lined by flat endothelial lining cells.
5. PORTAL TRACT
• Portal tract contains three main structures :
Largest is a terminal branch of hepatic portal vein.
Small diameter thick walled vessels are terminal branches of
hepatic artery.
A network of bile canaliculi is located with in each plate of
hepatocytes. These drain into bile collecting ducts known as Canals
of Hering which in turn drain into bile ductules.
The bile ductules merge to form larger more centrally located
trabecular ducts which drain via intrahepatic ducts into right and
left hepatic ducts, the common hepatic duct and then to duodenum
via common bile duct.
6. Portal tracts are triangular to round structures which contain pre-terminal and terminal portal veins
(arrowhead), terminal branches of hepatic artery (arrow with tail), and bile ducts (big arrow)
embedded in fibrous connective tissue. The portal tract is bounded by a discontinuous lining of
hepatocytes called the limiting plate (curved arrow).
7.
8. Liver is divided histologically into lobules. The center of the lobule is the central vein. At the periphery of
the lobule are portal triads. Functionally, the liver can be divided into three zones, based upon oxygen supply.
Zone 1 encircles the portal tracts where the oxygenated blood from hepatic arteries enters. Zone 3 is located
around central veins, where oxygenation is poor. Zone 2 is located in between.
11. • Also called hepatic vein thrombosis.
• Common form of venous outflow obstruction
• BCS is further separated into –
o Primary BCS when related to a primarily venous disease
(thrombosis or phlebitis).
o Secondary BCS when related to compression or invasion by a
lesion originating outside the veins (benign or malignant tumor
abscess, cyst, etc.)
• Obstruction of the hepatic venous outflow tract can be classified
according to its location: small hepatic veins (HVs), large HVs,
inferior vena cava (IVC), and combined obstruction of large HVs and
IVC.
12. CAUSES:
1. Idiopathic (one-third of cases)
2. Congenital:
▫ web in the hepatic vein
▫ interruption of the diaphragm
3. Venous thrombosis secondary to:
▫ Dehydration
▫ Septicemia
▫ Polycythemia rubra vera
▫ Antiphospholipid antibody syndrome
▫ Pregnancy
▫ Oral contraceptive pill
▫ Sickle cell disease
▫ Thrombocytosis
▫ Paroxysmal nocturnal hemoglobinuria
13. 4. Injury and/or inflammation secondary to:
▫ Phlebitis: bone marrow transplant and chemoradiotherapy
▫ Autoimmune disease
▫ Tumour invasion, e.g. renal cell carcinoma, hepatocellular
carcinoma, adrenal carcinoma.
▫ leiomyosarcoma of inferior vena cava
14. CLINICAL FEATURES :
• Acute symptoms :
o Hepatomegaly
o RUQ abdominal pain
o Nausea and vomiting
o Ascites
• Chronic symptoms :
o Sequelae of cirrhosis and portal hypertension
o Variceal bleeding
o Bacterial peritonitis
o Encephalopathy
15. •Gross-
▫Swollen liver with red-purple, tense capsule
•Microscopy-
▫Severe centrilobular congestion/necrosis, progressing
to centrilobular fibrosis.
▫Large regenerative nodules, focal nodular hyperplasia
and hepatocellular adenomas can be seen.
16. CASE HISTORY :
• A 22 year old hindu male, presented to the OPD with chief complaints
of pain abdomen, nausea, vomiting, fatigue, malaise, low grade fever and
yellowish discoloration of urine since around 1 month. On physical
examination their was icterus, pallor present. Per abdomen examination
show distension of abdomen ?ascites, tenderness in right hypochondrium.
Hematological parameters were normal with mild anemia. Biochemical
parameters show abnormal LFT. CT Scan show homogeneous mottled
liver with delayed enhancement in the periphery of the liver and around
the hepatic veins (nutmeg liver) along with caudate lobe enlargement.
The surgeons kept the differential diagnosis as chronic liver disease ?
Budd chiari syndrome with cholelithiasis.
• The liver was transplanted and the diseased liver of recepient came for
histopathological examination.
17. • On Gross examination, formalin fixed specimen consists of
liver measuring 17x16x7cm. Falciparum ligament and
caudate lobe was identified. Right lobe was markedly
hypertrophied and left lobe appears to be ?slighly
hypertrophied. External surface was grey brown, cut surface
was grey white to pale brown. Attached gall bladder
measures 6x2.5cm, its external surface was grey white,
luminal surface was greenish velvety with wall thickness of
0.2cm. No stones were present.
• The sections were given from different areas of liver
parenchyma, portal area and gall bladder
18. • On microscopy, various sections given from different areas
shows marked congestion with dilated central vein and
sinusoids. Their was loss of hepatic architecture with
extensive fibrosis involving portal areas and centrilobular
area. Their was also intra lobular fibrosis. The portal area
show marked infilteration by chronic inflammatory cells with
focal proliferation of bile ductules. Their was extensive areas
of fatty change.
• Gall bladder shows chronic cholecystitis.
• Overall, picture was suggestive of cirrhosis and morphology
is consistent with Budd chiari syndrome.
25. CIRRHOSIS
• Term was 1st coined by Laennec in 1826
• Many definitions but common theme is injury, repair,
regeneration and scarring
• NOT a localized process; involves entire liver
• Cirrhosis is a pathological diagnosis, characterized by
widespread fibrosis with nodular regeneration.
• Its presence implies previous or continuing hepatic cell damage.
• The three main characteristics of cirrhosis are:
▫ Bridging fibrous septa
▫ Parenchymal nodules containing replicating hepatocytes
▫ Disruption of the architecture of the entire liver
26.
27. POST NECROTIC CIRRHOSIS
•Post-necrotic cirrhosis, also termed post-hepatitic
cirrhosis, macronodular cirrhosis and coarsely nodular
cirrhosis, is characterised by large and irregular nodules
with broad bands of connective tissue and occurring
most commonly after previous viral hepatitis.
•Pathophysiology-
Broad bands of scar tissue resulted from viral, toxic, or
autoimmune hepatitis
28. ETIOLOGY
• Viral hepatitis - About 25% of patients give history of recent or remote
attacks of acute viral hepatitis followed by chronic viral hepatitis. Most
common association is with hepatitis B and C; hepatitis A is not known
to evolve into cirrhosis.
• Drugs and chemical hepatotoxins. - such as phosphorus, carbon
tetrachloride, mushroom poisoning, acetaminophen and α-methyl dopa.
• Others - Certain infections (e.g. brucellosis), parasitic infestations (e.g.
clonorchiasis), metabolic diseases (e.g. Wilson’s disease or
hepatolenticular degeneration) and advanced alcoholic liver disease may
produce a picture of post-necrotic cirrhosis.
• Idiopathic - etiology is unknown.
29. Signs
•Loss of hair (alopecia)
•Icterus
•Pallor
•Fetor hepaticus
•Loss of axillary & pubic hair
•Spider nevi
•Gynecomastia
30. Signs
• Glossitis
• Palmar erythema
• Clubbing
• Dupuytren’s contracture
• Ascites
• In 70 % cases liver is enlarged, firm
• Splenomegaly
• Caput medusae
35. Complications
• Upper gastrointestinal hemorrhage
• Hepatic encephalopathy
• Infection
• Hepatorenal syndrome
• Hepatopulmonary Syndrome
• Primary carcinoma of the liver
• Disturbance of electrolyte and acid-base balance
36. • GROSS :
The liver is usually small, weighing less than 1 kg, having distorted
shape with irregular and coarse scars and nodules of varying size.
Sectioned surface shows scars and nodules varying in diameter from 3
mm to a few centimeters.
37.
38. MICROSCOPY
• Nodular pattern: The normal lobular architecture of hepatic parenchyma
is mostly lost and is replaced by nodules larger than those in alcoholic
cirrhosis. However, uninvolved portal tracts and central veins in the
hepatic lobules can still be seen in some parts of surviving parenchyma.
• Fibrous septa: The fibrous septa dividing the variable sized nodules are
generally thick.
• Necrosis, inflammation and bile duct proliferation: Active liver cell
necrosis is usually inconspicuous. Fibrous septa contain prominent
mononuclear inflammatory cell infiltrate. Often there is extensive
proliferation of bile ductules derived from collapsed liver lobules.
• Hepatic parenchyma: Liver cells vary considerably in size and multiple
large nuclei are common in regenerative nodules. Fatty change may or
may not be present in the hepatocytes.
39.
40. Staging and Liver Fibrosis
Two important concepts for consideration:
• Stage is more than histologic fibrosis:
An integrated clinical/pathophysiologic approach is needed to
accurately stage the disease
• Cirrhosis is not the “end” of the story:
Histologic scoring may need to evolve to identify regression or
remodeling of cirrhosis, and evaluate for very advanced
nonreversible, or “end-stage” cirrhosis, based on degree of
fibrosis
41. Patterns of Fibrosis
Two major patterns for early scarring of the liver
• Portal-based Fibrosis: Injury begins in periportal
area
• Central-based Fibrosis: Injury begins in
centrilobular zone
42. GRADING AND SCORING
• Knodell System
▫ The first chronic hepatitis scoring system to systematically
categorize liver inflammation and fibrosis
▫ Three categories of necroinflammatory activity (periportal injury
with or without bridging necrosis, lobular injury and portal
inflammation) and degree of fibrosis
▫ These are assigned numeric values, which are added to obtain a
Hepatic Activity Index (HAI) that ranges from 0 to 22
▫ Major criticism is the inclusion of fibrosis (stage) as a determinant
of activity (grade)
43. • Ishak Modification of Hepatitis Activity Index
▫ The major changes were eliminating the combined score, and
separating confluent necrosis, including bridging necrosis, into
a fourth category of necroinflammatory activity
▫ Also includes a stage of 'developing cirrhosis', which is
important to assess the progression of fibrosis
▫ A description of all aspects of viral injury is helpful
▫ However, because of its extensive details, it remains more
useful for research purposes than routine liver biopsy reporting
44. 0 No fibrosis
1 Expansion of some portal areas with or
without septa
2 Expansion of most portal areas with or
without septa
3 Expansion of most portal areas with
occasional portal to
portal bridging
4 Expansion of portal areas with marked
bridging (portalportal
and/or portal-central)
5 Marked bridging with occasional nodules
(incomplete
cirrhosis)
6 Cirrhosis, probable or definitive
45. • METAVIR System
▫ This grading system evaluates only 2 features (periportal
necrosis and lobular necroinflammatory activity)
▫ Portal inflammation is excluded because it is considered a
prerequisite for the diagnosis of chronic hepatitis, even
when there is no parenchymal activity
▫ It is a relatively simple system, providing scores of mild,
moderate or severe for activity and four stages of
progression of fibrosis
46.
47. HISTOLOGICAL ACTIVITY FIBROSIS STAGE
No activity = A0 F0 = No fibrosis
Mild activity = A1 F1 = Portal fibrosis without septa
Moderate activity = A2 F2 = Portal fibrosis with rare septa
Severe activity = A3 F3 = Numerous septa without cirrhosis
F4 = Cirrhosis
48. • Scheuer System
▫ This also is a fairly simple system
▫ Only two categories are included (portal / periportal and lobular)
for evaluation of activity
• Batts-Ludwig System
▫ Uses five categories (0 to 4) separately for both grade and stage
▫ Grade is determined by evaluation of degree of interface activity,
lobular inflammation and necrosis
▫ Stage is scored from 0 (no fibrosis) to 4 (cirrhosis)
▫ It provides a pictorial description of each grade and stage of the
disease
51. REPORTING
• Each diagnosis in a liver biopsy for chronic hepatitis should include:
▫ A statement that it is chronic hepatitis
▫ The grade of necroinflammatory activity (name of the scoring system used)
▫ The stage of activity (name of the scoring system used)
▫ The known or suspected etiology
• Examples:
▫ Chronic hepatitis B, Metavir, grade 2/4 and stage 2/4 (fibrous septa)
▫ Chronic hepatitis, Batts-Ludwig, grade 2/4 and stage 4/4 (cirrhosis),
compatible with hepatitis C
52.
53. • Pathological hallmark of cirrhosis is :
oDevelopment of scar tissue that replaces normal parenchyma, blocking the
portal flow of blood through the organ and disturbing normal function.
oRecent research shows the pivotal role of a stellate cell, a cell type that
normally stores vitamin A, in the development of cirrhosis.
oDamage to the hepatic parenchyma leads to activation of the stellate cell,
which becomes contractile (called myofibroblast) and obstructs blood flow in
the circulation.
oIt secretes TGF-β1, which leads to a fibrotic response and proliferation of
connective tissue.
oIt disturbs the balance between matrix metalloproteinases and the naturally
occurring inhibitors (TIMP 1 and 2), leading to matrix breakdown and
replacement by connective tissue-secreted matrix.
54. CASE REPORT :
A 25 year old male was a known case of Hepatitis B related cirrhosis. The
cirrhotic liver of recepient came for histopathological examination.
GROSS-
Formalin fixed specimen consists of liver with gall bladder. Liver measuring
11.5x10x5 cm. External surface is grey white and micronodular. Cut surface is
grey white with areas of congestion. Gall bladder measures 6x2.5 cm. external
surface is grey white, cut surface is grey brown with wall thickness of 0.7cm. No
stones were present.
The sections were given from different areas of liver and gall bladder.
55. Microscopy:
Multiple sections were studied and show complete loss of hepatic
archietecture with formation of pseudolobules of varying sizes. The
portal and intralobular areas show extensive fibrosis by loose fibrous
tissue and infiltration by chronic non specific inflammatory cells. The
portal area show … proliferation. The periportal show only focal mild
interface … . Significant lobular infiltration and necrosis was not seen.
Overall, picture indicates cirrhosis. The morphology is suggestive of
Post-Necrotic Cirrhosis.
METAVIR Score: Histological activity score :- 1 (mild)
Fibrosis score :- 4 (cirrhosis)
64. • Cholangiocarcinoma is the designation used for
malignancy of the biliary tree, arising from bile
ducts within and outside of the liver.
•It is the second most common primary malignant
tumor of liver after HCC.
65. • It is of two types:
1.Intrahepatic
2.Extrahepatic
• Extrahepatic: it includes perihilar tumor known as Klatskin Tumors, which are
located at junction of right and left hepatic ducts. 50-60% are perihilar, 20-30%
are distal tumor arising from common bile ducts. Patients presents with
symptoms of biliary obstruction, cholangitis and RUQ pain.
• Intraheaptic: accounts 10%. The median time from diagnosis to death is 6
months. Patients comes to attention beacause of obstruction of bile flow and
symptomatic liver mass.
66. • Tumors of intrahepatic bile duct are less common than those of
hepatocytes.
• Risk factors-
▫ HCV related cirrhosis
▫ Caroli’s disease (congenitally dilated intrahepatic bile ducts)
▫ Clonorchis sinensis and opisthorchis infestation (parasitic)
▫ Anabolic steroid administration
• Occurs after 60 yrs of age
• Presents as abdominal pain & weight loss.
• Cholangiocarcinoma spread locally into portal area and metastasise
to both regional lymph nodes and to distant organs.
67. •Grossly-
▫firmer & whiter than Liver Cell Carcinoma
because of their greater amount of fibrous
stroma.
▫Arise close to the hilar region, but can occur
anywhere, including subsapsular region.
•Multicentricity is common.
68.
69. Microscopically-
• Its an adenocarcinoma, the duct like structures being lined
by cuboidal or columnar cells.
• A cribriform pattern may be present.
• Tumor has a tendency to spread b/w hepatocyte plates,
along duct wall, and in relation to nerves.
• Stroma is abundant, is sometimes arranged circumferentially
around the neoplastic glands.
• The prominent sinusoidal pattern of liver cell carcinoma is
absent.
• Mucin stains is nearly always positive.
71. IHC-
• Reactive for keratin, EMA, CEA
• A diagnostically useful difference in keratin immunoprofile between
intra hepatic and extra hepatic cholangiocarcinoma is that, the
former is positive for CK7+/CK20+ whereas latter is CK7+/CK20-.
• The tumour also stains for tissue polypeptide antigen, amylase
isoenzymes and PTH related peptides.
Treatment-
partial or total hepatic resection, followed by liver transplantation.
72.
73.
74.
75. Case presentation:
Left lobe of liver with gall bladder and lymph nodes of a 55 year old female came for
histopathological examination.
GROSS-
Formalin fixed specimen consists of partial specimen of liver with gall bladder
collectively measuring 18x10x8 cm. Falciparum ligament was identified. External
surface is grey brown with multiple projecting nodules ?satellite nodules. On
cutting, grey white growth is seen in left lobe measuring 4x2.5 cm. Multiple grey
white area is seen in liver parenchyma ranging in size from 0.2 to 0.6 cm in
diameter. Gall bladder measures 7x3.5 cm. External surface is grey white to grey
brown. Luminal surface is greenish velvety with wall thickness of 0.2 cm. No
stones were present.
?Lymph node- Formalin fixed specimen consists of several grey white to grey brown
soft tissue pieces collectively measuring 2x1.5 cm.
76. • Various sections were taken from resected margins, margins from deeper tissue,
resected end of hilum, growth, satellite nodules, gall bladder and lymph nodes.
MICROSCOPY-
Liver shows moderately differentiated adenocarcinoma. The features are
suggestive of cholangiocarcinoma. Sections from satellite nodules show
moderately differentiated adenocarcinoma. The associated nerve bundle show
focal infiltration by tumor cells. The lymphovascular invasion was not seen. The
section from resected margins show focal infiltration by tumor cells. Section from
hilar area appears to be free from tumor invasion. The hepatic parenchyma show
marked infiltration by chronic non specific inflammatory cells, congested
sinusoids and bile stasis.
Gall bladder show chronic cholecystitis.
All the five lymph nodes resected show reactive hyperplasia. No evidence of
malignancy seen.
77.
78.
79.
80. FEATURES LIVER CELL
CARCINOMA
CHOLANGIOCARCINOMA
Cell of origin Hepatocyte Bile duct cells
Spread Venous Lymphatics
Age Young Older
Sex Males None
Presence of cirrhosis Common Exceptional
Liver cell dysplasia May be present Absent
Alpha-fetoprotein Present Absent
Bile production May be present Absent
Mucin secretion Absent Present
Gross Soft & h’gh Hard & whitish